Catalano Peter, Goh Yao Hong, Romanow John
Lahey Clinic, Burlington, MA 01805, USA.
Otolaryngol Head Neck Surg. 2007 Jul;137(1):105-9. doi: 10.1016/j.otohns.2007.01.038.
To evaluate safety and efficacy of additional palatal implants for snoring treatment.
A prospective case series at two clinical sites in an office setting. Patients who did not have an acceptable reduction in snoring intensity after an initial 3 implant procedure received additional implants. Bed partners rated snoring intensity on a 10 cm visual analog scale (VAS) at baseline and 90 days postprocedure.
Snoring intensity VAS decreased significantly from 6.4 +/- 2.3 to 4.6 +/- 2.9 (P < 0.01) for patients who received an additional fourth implant, and to 4.1 +/- 2.8 after the 5th implant (P<0.01). Epworth sleepiness scale scores also decreased significantly for patients who received additional fourth or fifth implants. There were no adverse events.
Additional palatal implants for snoring treatment were safe and effective in this case series.
Additional implants may offer relief for snorers not responding to the initial 3 implant procedure.
评估额外的腭部植入物治疗打鼾的安全性和有效性。
在两个临床地点的办公室环境中进行的前瞻性病例系列研究。在最初进行3枚植入手术后打鼾强度未得到可接受程度降低的患者接受了额外的植入物。床伴在基线和术后90天时使用10厘米视觉模拟量表（VAS）对打鼾强度进行评分。
接受额外第4枚植入物的患者，打鼾强度VAS评分从6.4±2.3显著降至4.6±2.9（P<0.01），在接受第5枚植入物后降至4.1±2.8（P<0.01）。接受额外第4枚或第5枚植入物的患者，爱泼沃斯嗜睡量表评分也显著降低。未发生不良事件。
在该病例系列中，额外的腭部植入物治疗打鼾安全有效。
额外的植入物可能为对最初3枚植入手术无反应的打鼾者提供缓解。
